Not associated with the characteristic regulatory mechanisms of p53 WT, including the inability to bind to DNA to promote MDM2 transcription, mutant p53 accumulated in the cell will become an active antigen in order to generate a more intense response to immunotherapy, resulting in cancer cell death. This evidence concerns the gene TP53 and cancer.